Statement Of Deviation Of Funds For The Quarter Ended 30Th June 2026
Filed with BSE · · 2 pages · English
Summary by 6ix AI
The filing includes the approval of unaudited financial results and the appointment of internal auditors for the fiscal year. It confirms that there was no deviation in the utilization of funds raised through a preferential issue. The report outlines the original purposes for which the funds were raised and confirms compliance with the stated objectives.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
(formerly known as Genesis IBRC India Limited) CIN: L46909AP1992PLC107068 Regd. Off: Flat No: 401, VVN Residency, 40-A, Ashok Nagar, Eluru, Andhra Pradesh 534002 Corp. Office: 501, 5th Floor, A Wing, Navkar Chambers, Opp. Star Plus, Marol Naka, Andheri Kurla Road, Andheri East, Mumbai - 400059 Tel: 08829-256599, Website: www.genesisiil.com, Email: [email protected] Date: August 14, 2026 Ref.:
Earlier from CCME Global
- Announcement under Regulation 30 (LODR)-Change in Management
- Results For The Quarter Ended 30Th June 2026
- Board Meeting Outcome for Outcome Of Board Meeting Held On 14Th August 2026
- Ccme Global Ltd Press Release Aug 10 2026
- Board Meeting Intimation for Intimation Of Board Meeting Scheduled To Be Held On 14Th August 2026
Later from CCME Global
- Announcement under Regulation 30 (LODR)-Demise
- Ccme Global Ltd Press Release Aug 18 2026
- Board Meeting Outcome for Outcome Of Board Meeting Held On August 21, 2026.
- Ccme Global Ltd Press Release Aug 21 2026
- Board Meeting Outcome for Outcome Of Board Meeting Held On 29Th August 2026
Follow CCME Global into a list and get an email when it puts out news.
Follow CCME Global